SCHEMBL6565475

SCHEMBL6565475

CC(=O)CCCC1=CCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 6/20 0.41
ALOX15 P16050 2/20 0.40
HPGD P15428 4/20 0.39
HTT P42858 4/20 0.39
MAPT P10636 3/20 0.39
HSD17B10 Q99714 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
TSHR P16473 1/20 0.38
NPC1 O15118 6/20 0.38
RAB9A P51151 6/20 0.38
LMNA P02545 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
EPHX1 P07099 1/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9812097 0.89 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2ALOX15
SCHEMBL12132006 0.85 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ASMN1; SMN2HPGD
SCHEMBL2220979 0.83 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ASMN1; SMN2ALOX15
SCHEMBL987088 0.79 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ASMN1; SMN2ALOX15
SCHEMBL28343241 0.79 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL4558608 0.78 F13A1 (0.47) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL2477399 0.78 F13A1 (0.47) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL31261412 0.78 F13A1 (0.47) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL9533116 0.78 F13A1 (0.47) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL27641655 0.78 F13A1 (0.47) ALDH1A1MEN1KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1067118-B1 Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances GIVAUDAN SA (CH) 2004-03-31 EP disclosed
US-6441052-B1 ALKANOL, ALDEHYDE, AND KETONE CYCLOPENTA DERIVATIVES; FRAGRANCES GIVAUDAN SA (CH) 2002-08-27 US disclosed
US-20020086901-A1 CYCLOPENTYLALKYL-NITRILES GIVAUDAN SA, A SWITZERLAND CORPORATION 2002-07-04 US disclosed
US-6410000-B1 PERFUME GIVAUDAN SA (CH) 2002-06-25 US disclosed
US-6399811-B1 ORGANOLEPTIC GIVAUDAN SA (CH) 2002-06-04 US disclosed
EP-1067118-A1 Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances Givaudan SA (CH) 2001-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020086901-A1 CYCLOPENTYLALKYL-NITRILES CCRL2, CBR1, CNR1 ALDH1A1 479/4885MEN1 1470/4885KMT2A 2948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.